Thursday, January 20, 2011

Looking at the Legal Costs in Avandia v. Vioxx

RofecoxibImage via WikipediaInteresting read which should lead as a discussion point for some lawyers. In a recent Forbes.com post, the author commented on the legal bills related to each drug. GSK has spent $6 Billion to defend cases involving Avandia while Merck spent $4 Billion to settle all of Vioxx.

Read it here: Link.http://blogs.forbes.com/matthewherper/2011/01/18/which-is-worse-vioxx-or-avandia/ 
Enhanced by Zemanta